Combinatorial RNA-based gene therapy for the treatment of HIV/AIDS

The design and evaluation of HIV-1 vaccines

(2012) Kevin O. Saunders et al.   AIDS

Hematopoietic-Stem-Cell-Based Gene Therapy for HIV Disease

(2012) Hans-Peter Kiem et al.   Cell Stem Cell

Creating genetic resistance to HIV

(2012) John C Burnett et al.   CURRENT OPINION IN IMMUNOLOGY

Current translational and clinical practices in hematopoietic cell and gene therapy

(2012) David L. Digiusto et al.   CYTOTHERAPY

HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults

(2012) Steven E Lipshultz et al.   Expert Review of Anti-Infective Therapy

Renal Toxicity Associated With Antiretroviral Therapy

(2012) Leonardo Calza   HIV CLINICAL TRIALS

HIV Medications

(2012) E. Kelly Hester   NUTRITION IN CLINICAL PRACTICE

Can immunotherapy be useful as a “functional cure” for infection with Human Immunodeficiency Virus-1?

(2012) Guido Vanham et al.   Retrovirology

Liver Toxicity of Antiretroviral Drugs

(2012) Michelle Jones et al.   SEMINARS IN LIVER DISEASE

Reaping the prevention benefits of highly active antiretroviral treatment

(2012) Andrew D. Forsyth et al.   Current Opinion in HIV and AIDS

The power of 1 in HIV therapeutics

(2011) R. Parker et al.   BLOOD

Modelling the Impact of Antiretroviral Therapy on the Epidemic of HIV

(2011) Brian G. Williams et al.   CURRENT HIV RESEARCH

Drug combinations for HIV: what’s new?

(2011) Andrew Scourfield et al.   Expert Review of Anti-Infective Therapy

Current progress and challenges in HIV gene therapy

(2011) Janet Chung et al.   Future Virology

Ex vivo gene transfer and correction for cell-based therapies

(2011) Luigi Naldini   NATURE REVIEWS GENETICS

Antiretroviral therapy in treatment-naïve patients with HIV infection

(2011) Ricardo Camacho et al.   Current Opinion in HIV and AIDS

Evidence for the cure of HIV infection by CCR5 32/ 32 stem cell transplantation

(2010) K. Allers et al.   BLOOD

Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics

(2010) John S. Albin et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

HIV-1 Vif versus the APOBEC3 cytidine deaminases: An intracellular duel between pathogen and host restriction factors

(2010) Silke Wissing et al.   MOLECULAR ASPECTS OF MEDICINE

Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo

(2010) Nathalia Holt et al.   NATURE BIOTECHNOLOGY

Anti-retroviral activity of TRIM5α

(2010) Emi E. Nakayama et al.   REVIEWS IN MEDICAL VIROLOGY

RNA-Based Gene Therapy for HIV with Lentiviral Vector-Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma

(2010) D. L. DiGiusto et al.   Science Translational Medicine

BST-2/tetherin: a new component of the innate immune response to enveloped viruses

(2010) David T. Evans et al.   TRENDS IN MICROBIOLOGY

The Great Escape: Viral Strategies to Counter BST-2/Tetherin

(2010) Janet L. Douglas et al.   PLoS Pathogens

A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model

(2009) S. Shimizu et al.   BLOOD

Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O6-methylguanine-DNA methyltransferaseP140K

(2009) P Maier et al.   GENE THERAPY

Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo

(2009) H-P Kiem et al.   GENE THERAPY

RNAi-mediated CCR5 Silencing by LFA-1-targeted Nanoparticles Prevents HIV Infection in BLT Mice

(2009) Sang-Soo Kim et al.   MOLECULAR THERAPY

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

(2009) Ronald T Mitsuyasu et al.   NATURE MEDICINE

Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell Transplantation

(2009) Gero Hütter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

(2009) Supachai Rerks-Ngarm et al.   NEW ENGLAND JOURNAL OF MEDICINE

Protection of Stem Cell-Derived Lymphocytes in a Primate AIDS Gene Therapy Model after In Vivo Selection

(2009) Grant D. Trobridge et al.   PLoS One

Multiple ways of targeting APOBEC3–virion infectivity factor interactions for anti-HIV-1 drug development

(2009) Jessica L. Smith et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Use of A U16 snoRNA-containing Ribozyme Library to Identify Ribozyme Targets in HIV-1

(2008) Hoshang J Unwalla et al.   MOLECULAR THERAPY